Literature DB >> 10098257

Evaluation of cardiac troponin I immunoreaction in autopsy hearts: a possible marker of early myocardial infarction.

S H Hansen1, K Rossen.   

Abstract

Postmortem diagnosis of early myocardial infarctions is an ever recurrent problem in pathology. In the present study we determined the troponin I expression in 46 autopsy hearts using an immunohistochemical technique. Troponin I has, as a specific cardiac muscle protein, become a widespread used marker in testing patients with acute chest pain. The hearts were divided into three groups based on the macroscopical findings: definite signs of infarction, possible signs of infarction and no signs of infarction. All 14 cases of definite myocardial infarction showed a well-defined area with loss of troponin I. Twenty-three of 24 cases of possible myocardial infarction also showed a well-defined area with loss of troponin I. None of the eight non-cardiac death controls showed loss of troponin I expression. The results suggest troponin I expression as a sensitive test in diagnosis of early myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10098257     DOI: 10.1016/s0379-0738(98)00193-5

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  14 in total

Review 1.  Acp. Best practice no 155. Pathological investigation of deaths following surgery, anaesthesia, and medical procedures.

Authors:  R D Start; S S Cross
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

2.  Magnetic resonance imaging goes postmortem: noninvasive detection and assessment of myocardial infarction by postmortem MRI.

Authors:  Christian Jackowski; Marcel J B Warntjes; Johan Berge; Walter Bär; Anders Persson
Journal:  Eur Radiol       Date:  2010-07-20       Impact factor: 5.315

3.  Immunohistochemical study on dystrophin expression in CAD-related sudden cardiac death: a marker of early myocardial ischaemia.

Authors:  Cristina Mondello; Luigi Cardia; Giovanni Bartoloni; Alessio Asmundo; Elvira Ventura Spagnolo
Journal:  Int J Legal Med       Date:  2018-05-07       Impact factor: 2.686

4.  Bioreducible polymer-transfected skeletal myoblasts for VEGF delivery to acutely ischemic myocardium.

Authors:  Arlo N McGinn; Hye Yeong Nam; Mei Ou; Norman Hu; Catherine M Straub; James W Yockman; David A Bull; Sung Wan Kim
Journal:  Biomaterials       Date:  2010-11-05       Impact factor: 12.479

Review 5.  Immunohistochemical detection of early myocardial infarction: a systematic review.

Authors:  Cristina Mondello; Luigi Cardia; Elvira Ventura-Spagnolo
Journal:  Int J Legal Med       Date:  2016-11-25       Impact factor: 2.686

Review 6.  Molecular tissue changes in early myocardial ischemia: from pathophysiology to the identification of new diagnostic markers.

Authors:  Aleksandra Aljakna; Tony Fracasso; Sara Sabatasso
Journal:  Int J Legal Med       Date:  2018-01-23       Impact factor: 2.686

7.  A cardiac troponin I study in a minimally invasive myocardial infarction canine model.

Authors:  Reyaj Mikrani; Cuilan Liang; Muhammad Naveed; Asghar Ali Kamboh; Muhammad Abbas; Birendra Chaurasiya; Li Xue; Zhou Xiaohui
Journal:  J Appl Biomed       Date:  2018-11-23       Impact factor: 1.797

8.  Can early myocardial infarction-related deaths be diagnosed using postmortem urotensin receptor expression levels?

Authors:  Mustafa Talip Sener; Emre Karakus; Zekai Halici; Erol Akpinar; Atilla Topcu; Ahmet Nezih Kok
Journal:  Forensic Sci Med Pathol       Date:  2014-06-18       Impact factor: 2.007

9.  Loss of dystrophin staining in cardiomyocytes: a novel method for detection early myocardial infarction.

Authors:  Satwat Hashmi; Suhail Al-Salam
Journal:  Int J Clin Exp Pathol       Date:  2013-01-15

10.  Immunohistochemical detection of S100A1 in the postmortem diagnosis of acute myocardial infarction.

Authors:  Haitao Bi; Ying Yang; Jianye Huang; Yingmin Li; Chunling Ma; Bin Cong
Journal:  Diagn Pathol       Date:  2013-05-17       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.